Chinese mRNA Covid Shot Wins Approval in Indonesia

(Bloomberg) — A Chinese-developed mRNA Covid vaccine got its first emergency use authorization from Indonesian authorities, a tentative step in China’s efforts to gain ground on Western inoculations widely used around the world.

The shot, named AWcorna, was co-developed by Walvax Biotechnology Co., Suzhou Abogen Biosciences Co. and the Chinese military. It was cleared for use in people ages 18 and older, Walvax said in a statement. The halal-certified vaccine can be used as either a primary or a booster dose, it said.